Changed delivery of boron to tumours using electroporation for boron neutron capture therapy with BSH

British Journal of Radiology

Volumn 73, Issue 866, 2000, Pages 195-200

  Cemazar M ^a   Skrk J ^a   Mitrovic B ^b   Serša, Gregor ^a  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

^b JO EF STEFAN INSTITUTE   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

BORON 10;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LEVEL; CELL STRAIN MCF 7; DRUG DELIVERY SYSTEM; ELECTROPORATION; EXPERIMENTAL MELANOMA; EXPERIMENTAL MODEL; FEMALE; HUMAN; HUMAN CELL; MELANOMA B16; MOUSE; NEUTRON CAPTURE THERAPY; NONHUMAN; RADIATION DOSE; RADIOISOTOPE DISTRIBUTION; TUMOR;

EID: 0343963020     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.73.866.10884734     Document Type: Article

References (23)

1. Perez CA, Brady LW, editors. Principles and practice of radiation oncology (3rd edn). New York: Lippincott-Raven Publishers, 1998.
2. Gabel D. Present status and perspectives of boron neutron capture therapy. Radiother Oncol 1994;30: 199-205.
3. Nguyen T, Brownell GL, Holden SA, Teicher BA. Intracellular distribution of various boron compounds for use in boron neutron capture therapy. Biochem Pharmacol 1993;45:147-55.
4. Yanagie H, Fuji Y, Sekiguchi M, Nariuchi H, Kobayashi T, Kanda K. A targeting model of boron neutron capture therapy to hepatoma cells in vivo with a boronated anti-(a-fetoprotein) monoclonal antibody. J Cancer Res Clin Oncol 1994;120: 636-40.
5. Yang W, Barth RF, Adams DM, Soloway AH. Intratumoral delivery of boronated epidermal growth factor for neutron capture therapy of brain tumors. Cancer Res 1997;57:4333-9.
6. Ono K, Masunaga S, Kinashi Y, Takagaki M, Akaboshi M, Suzuki. M, et al. Effects of boron neutron capture therapy using borocaptate sodium in combination with a tumor-selective vasoactive agent in mice. Jpn J Cancer Res 1998;89:334-40.
7. Masunaga S, Ono K, Suzuki M, Takagaki M, Sakurai Y, Kobayashi T, et al. Modification of the response of a quiescent cell population within a murine solid tumour to boron neutron capture irradiation: studies with nicotinamide and hyperthermia. Br J Radiol 1997;70:391-8.
8. Ceberg CP, Brun A, Mir LM, Persson BRR, Salford LG. Enhanced boron uptake in RG2 rat gliomas by electropermeabilization in vivo - a new possibility in boron neutron capture therapy. Anti-Cancer Drugs 1994;5:463-6.
9. Lemmen P, Weisfloch L, Auberger T, Probst T. Uptake and distribution of the boron-containing ether lipid B-Et-11-Ome in tumor-bearing mice. Anti-Cancer Drugs 1995;6:744-8.
10. Mishima Y, Honda C, Ichihashi M, Obara H, Hiratsuka J, Fukuda H, et al. Treatment of malignant melanoma by single thermal neutron capture therapy with melanoma-seeking 10B-compound. Lancet 1989;2:388-9.
11. Orlowski S, Mir LM. Cell electropermeabilization: a new tool for biochemical and pharmacological studies. Biochim Biophys Acta 1993;1154:51-63.
12. Heller R, Jaroszeski M, Atkin A, Moradpur D, Gilbert R, Wands J, et al. In vivo gene electroinjection and expression in rat liver. FEBS Letters 1996; 389:225-8.
13. Mir LM, Orlowski S, Belehradek JR J, Tessie J, Rols MP, Serša G. et al. Biomedical applications of electric pulses with special emphasis on antitumor electrochemotherapy. Bioelectroch Bioener 1995;38: 203-7.
14. Serša G, Čemažar M, Miklavčič D. Antitumor effectiveness of electrochemotherapy with cis-Diamminedichloroplatinum (II) in mice. Cancer Res 1995;55:3450-5.
15. Čemažar M, Miklavčič D, Ščančar J, Dolžan V, Golouh R, Serša G. Increased platinum accumulation in SA-1 tumor cells after in vivo electrochemotherapy with cisplatin. Br J Cancer 1999;79: 1386-91.
16. Mir LM, Glass LF, Serša G, Teissie J, Domenge C, Miklavčič D, et al. Effective treatment of cutaneous and subcutaneous malignant tumors by electrochemotherapy. Br J Cancer 1998;77:2336-42.
17. Serša G, Štabuc B, Čemažar M, Jančar B, Miklavčič D, Rudolf Z. Electrochemotherapy with cisplatin: potentiation of local cisplatin antitumor effectiveness by application of electric pulses in cancer patients. Eur J Cancer 1998;34:1213-8.
18. Rudolf Z, Štabuc B, Čemažar M, Miklavčič D, Vodovnik L, Serša G. Electrochemotherapy with bleomycin: the first clinical experience in malignant melanoma patients. Radiol Oncol 1995;29:229-35.
19. Serša G, Čemažar M, Novakovič S, Rant J, Krištof E, Miklavčič U, et al. Radiation effect of boron neutron capture therapy on mouse melanoma and breast carcinoma cells in vitro. In: Larsson B, Crawford J, Weinreich R, editors. Advances in neutron capture therapy. Volume II, chemistry and biology. The Netherlands: Elsevier, 1997.
20. 10B-neutron capture therapy: enhancement of tumour dose via beam filtration and dose rate, and the effects of these parameters on minimum boron content: a theoretical evaluation. Int J Radiat Oncol Biol Phys 1985;11:831-40.
21. Serša G, Beravs K, Čemažar M, Miklavčič D, Demšar F. Contrast enhanced MRI assessment of tumor blood volume after application of electric pulses. Electro Magnetobiol 1998;17:299-306.
22. Serša G, Čemažar M, Parkins CS, Chaplin DJ. Blood modifying effects of electric pulses. Eur J Cancer 1999;35:672-7.
23. Pignol JP, Oudart H, Chauvel P, Sauerwein W, Gabel D, Prevot G. Selective delivery of 10B to soft tissue sarcoma using 10B-L-borophenylalanine for boron neutron capture therapy. Br J Radiol 1998; 71:320-3.